SCHEMBL9998505

SCHEMBL9998505

CCCC(=Cc1ccc(C(C)C)cc1)C(OC(C)=O)OC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 3/20 0.46
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
POLB P06746 1/20 0.41
KDM4E B2RXH2 5/20 0.41
MAPK1 P28482 1/20 0.41
TYR P14679 1/20 0.40
MAPT P10636 2/20 0.38
HPGD P15428 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
TP53 P04637 1/20 0.37
USP5 P45974 1/20 0.36
RXRA P19793 1/20 0.35
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998535 0.88 CYP2C9 (0.41) ALDH1A1KDM4EMAPK1MAPTCYP3A4
SCHEMBL9998533 0.88 CYP2C9 (0.41) ALDH1A1KDM4EMAPK1MAPTCYP3A4
SCHEMBL9997500 0.88 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL9998268 0.87 MAOB (0.39) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL9997624 0.87 MAPT (0.38) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL9997621 0.87 MAPT (0.38) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL9998270 0.87 MAOB (0.39) ALDH1A1SMN1; SMN2LMNARAB9ANPC1
SCHEMBL9997801 0.85 LMNA (0.47) ALDH1A1SMN1; SMN2LMNAPOLBKDM4E
SCHEMBL9998017 0.85 TRPA1 (0.48) LMNAKDM4EMAPTHPGDCYP2C9
SCHEMBL9997805 0.85 LMNA (0.47) ALDH1A1SMN1; SMN2LMNAPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ALDH1A1 160/4885SMN1; SMN2 3151/4885LMNA 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.